245 related articles for article (PubMed ID: 23712122)
1. Direct intraventricular delivery of drugs to the rodent central nervous system.
DeVos SL; Miller TM
J Vis Exp; 2013 May; (75):e50326. PubMed ID: 23712122
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System.
Chen Y; Mazur C; Luo Y; Sun L; Zhang M; McCampbell A; Tomassy GS
J Vis Exp; 2019 Oct; (152):. PubMed ID: 31736489
[TBL] [Abstract][Full Text] [Related]
3. A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration.
Monine M; Norris D; Wang Y; Nestorov I
J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):639-654. PubMed ID: 33991294
[TBL] [Abstract][Full Text] [Related]
4. Direct Administration and Gene Modulation Using Antisense Oligonucleotides Within the CNS.
Wahlestedt C; Khorkova O
Cell Mol Neurobiol; 2021 Jul; 41(5):849-853. PubMed ID: 32656646
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies.
Kim TW; Kim KS; Seo JW; Park SY; Henry SP
J Pharmacol Toxicol Methods; 2014; 69(1):49-60. PubMed ID: 24211663
[TBL] [Abstract][Full Text] [Related]
6. Development of a simple, rapid, and robust intrathecal catheterization method in the rat.
Mazur C; Fitzsimmons B; Kamme F; Nichols B; Powers B; Wancewicz E
J Neurosci Methods; 2017 Mar; 280():36-46. PubMed ID: 28163066
[TBL] [Abstract][Full Text] [Related]
7. The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration.
Jafar-Nejad P; Powers B; Soriano A; Zhao H; Norris DA; Matson J; DeBrosse-Serra B; Watson J; Narayanan P; Chun SJ; Mazur C; Kordasiewicz H; Swayze EE; Rigo F
Nucleic Acids Res; 2021 Jan; 49(2):657-673. PubMed ID: 33367834
[TBL] [Abstract][Full Text] [Related]
8. A single-cell map of antisense oligonucleotide activity in the brain.
Mortberg MA; Gentile JE; Nadaf NM; Vanderburg C; Simmons S; Dubinsky D; Slamin A; Maldonado S; Petersen CL; Jones N; Kordasiewicz HB; Zhao HT; Vallabh SM; Minikel EV
Nucleic Acids Res; 2023 Aug; 51(14):7109-7124. PubMed ID: 37188501
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNS.
Nagata T; Dwyer CA; Yoshida-Tanaka K; Ihara K; Ohyagi M; Kaburagi H; Miyata H; Ebihara S; Yoshioka K; Ishii T; Miyata K; Miyata K; Powers B; Igari T; Yamamoto S; Arimura N; Hirabayashi H; Uchihara T; Hara RI; Wada T; Bennett CF; Seth PP; Rigo F; Yokota T
Nat Biotechnol; 2021 Dec; 39(12):1529-1536. PubMed ID: 34385691
[TBL] [Abstract][Full Text] [Related]
10. Endosomal escape cell-penetrating peptides significantly enhance pharmacological effectiveness and CNS activity of systemically administered antisense oligonucleotides.
Dastpeyman M; Sharifi R; Amin A; Karas JA; Cuic B; Pan Y; Nicolazzo JA; Turner BJ; Shabanpoor F
Int J Pharm; 2021 Apr; 599():120398. PubMed ID: 33640427
[TBL] [Abstract][Full Text] [Related]
11. Delivery of Antisense Oligonucleotides to the Mouse Brain by Intracerebroventricular Injections.
Metz T; Kuijper EC; van Roon-Mom WMC
Methods Mol Biol; 2022; 2434():333-341. PubMed ID: 35213029
[TBL] [Abstract][Full Text] [Related]
12. Convective forces increase rostral delivery of intrathecal radiotracers and antisense oligonucleotides in the cynomolgus monkey nervous system.
Sullivan JM; Mazur C; Wolf DA; Horky L; Currier N; Fitzsimmons B; Hesterman J; Pauplis R; Haller S; Powers B; Tayefeh L; DeBrosse-Serra B; Hoppin J; Kordasiewicz H; Swayze EE; Verma A
J Transl Med; 2020 Aug; 18(1):309. PubMed ID: 32771027
[TBL] [Abstract][Full Text] [Related]
13. Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging.
Mazur C; Powers B; Zasadny K; Sullivan JM; Dimant H; Kamme F; Hesterman J; Matson J; Oestergaard M; Seaman M; Holt RW; Qutaish M; Polyak I; Coelho R; Gottumukkala V; Gaut CM; Berridge M; Albargothy NJ; Kelly L; Carare RO; Hoppin J; Kordasiewicz H; Swayze EE; Verma A
JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31619586
[TBL] [Abstract][Full Text] [Related]
14. Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model.
Hua Y; Sahashi K; Hung G; Rigo F; Passini MA; Bennett CF; Krainer AR
Genes Dev; 2010 Aug; 24(15):1634-44. PubMed ID: 20624852
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of antisense oligonucleotides to pancreatic β-cells.
Ämmälä C; Drury WJ; Knerr L; Ahlstedt I; Stillemark-Billton P; Wennberg-Huldt C; Andersson EM; Valeur E; Jansson-Löfmark R; Janzén D; Sundström L; Meuller J; Claesson J; Andersson P; Johansson C; Lee RG; Prakash TP; Seth PP; Monia BP; Andersson S
Sci Adv; 2018 Oct; 4(10):eaat3386. PubMed ID: 30345352
[TBL] [Abstract][Full Text] [Related]
16. Role of nitric oxide and beta-adrenoceptors of the central nervous system on the salivary flow induced by pilocarpine injection into the lateral ventricle.
Saad WA; Guarda IF; Guarda RS; Camargo LA; dos Santos TA; Saad WA; Simões S
Pharmacol Biochem Behav; 2002 May; 72(1-2):229-35. PubMed ID: 11900793
[TBL] [Abstract][Full Text] [Related]
17. Injection and Infusion of Compounds to the Central Nervous System.
Zamboni M
Methods Mol Biol; 2019; 2036():237-248. PubMed ID: 31410801
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Cell-Penetrating Peptide Delivery of Antisense Oligonucleotides for Therapeutic Efficacy in Spinal Muscular Atrophy.
Hammond SM; Abendroth F; Gait MJ; Wood MJA
Methods Mol Biol; 2019; 2036():221-236. PubMed ID: 31410800
[TBL] [Abstract][Full Text] [Related]
19. Targeted Delivery of Antisense Oligonucleotides Using Neurotensin Peptides.
Nikan M; Tanowitz M; Dwyer CA; Jackson M; Gaus HJ; Swayze EE; Rigo F; Seth PP; Prakash TP
J Med Chem; 2020 Aug; 63(15):8471-8484. PubMed ID: 32677436
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
